Literature DB >> 17845893

Osteoporosis risk factors and association with somatotypes in males.

Mahmut Saitoglu1, Ozge Ardicoglu, Salih Ozgocmen, Ayhan Kamanli, Arzu Kaya.   

Abstract

BACKGROUND: Osteoporosis is a systemic and metabolic skeletal disease characterized by reduced bone mass, changes in microarchitecture, and consequential increased fracture risk. Previous reports described a relationship between bone content with fat mass and lean body mass. In this study, we assessed osteoporosis risk factors and the association with somatotypes in males aged 45-65 years.
METHODS: Standard axial spine and proximal femur bone mineral density (BMD) were measured using dual x-ray (DXA) absorptiometry in 70 healthy men. Heath-Carter procedure was followed to assess individual's somatotype.
RESULTS: All body types were grouped as endomorphy, mesomorphy, and ectomorphy. Moderate to weak correlations were found between lumbar BMD with endomorphy and mesomorphy. Negative correlation was found between lumbar BMD and ectomorphy. Total femur BMD correlated positively with endomorphy and mesomorphy and negatively correlated with ectomorphy. Body mass index correlated weakly with lumbar, femur neck, and total femur BMD. Multiple regression analysis revealed that endomorphy was significantly related to BMD measurements at lumbar spine (standardized coefficient, SC = 0.51, p = 0.001), femur neck (SC = 0.52, p = 0.001), and total femur BMD (SC = 0.41, p = 0.01). Lumbar BMD and age, hand grip strength, smoking, tea and coffee consumption, calorie expenditure, calcium intake, PTH, albumin, total protein, sex hormone-binding globulin, and testosterone were not significantly correlated.
CONCLUSIONS: Endomorphy seems related to high BMD values at the lumbar spine and the proximal femur in middle-aged men. Somatotype together with daily calorie expenditure may be taken into account when assessing risk factors for male osteoporosis.

Entities:  

Mesh:

Year:  2007        PMID: 17845893     DOI: 10.1016/j.arcmed.2007.03.009

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  7 in total

1.  Multivitamin and mineral supplementation is associated with the reduction of fracture risk and hospitalization rate in Chinese adult males: a randomized controlled study.

Authors:  Shao-Ming Wang; Liang-Yu Yin; Yu Zhang; Jin-Hu Fan; Irene J Chang; Sanford M Dawsey; Philip R Taylor; Christian C Abnet; You-Lin Qiao
Journal:  J Bone Miner Metab       Date:  2014-05-22       Impact factor: 2.626

Review 2.  Green tea and bone metabolism.

Authors:  Chwan-Li Shen; James K Yeh; Jay J Cao; Jia-Sheng Wang
Journal:  Nutr Res       Date:  2009-07       Impact factor: 3.315

3.  Tea Consumption Is Associated with Increased Bone Strength in Middle-Aged and Elderly Chinese Women.

Authors:  H Huang; G-Y Han; L-P Jing; Z-Y Chen; Y-M Chen; S-M Xiao
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

4.  BFH-OSTM, a new predictive screening tool for identifying osteoporosis in elderly Han Chinese males.

Authors:  JiSheng Lin; Yong Yang; XiaoDong Zhang; Zhao Ma; Hao Wu; Yongjin Li; Xiuquan Yang; Qi Fei; Ai Guo
Journal:  Clin Interv Aging       Date:  2017-07-31       Impact factor: 4.458

5.  Updated association of tea consumption and bone mineral density: A meta-analysis.

Authors:  Zhao-Fei Zhang; Jun-Long Yang; Huan-Chang Jiang; Zheng Lai; Feng Wu; Zhi-Xiang Liu
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

6.  Relationship between Regular Green Tea Intake and Osteoporosis in Korean Postmenopausal Women: A Nationwide Study.

Authors:  Dan Bi Lee; Hong Ji Song; Yu-Jin Paek; Kyung Hee Park; Young-Gyun Seo; Hye-Mi Noh
Journal:  Nutrients       Date:  2021-12-26       Impact factor: 5.717

7.  Tea consumption and bone health in Chinese adults: a population-based study.

Authors:  X Li; Y Qiao; C Yu; Y Guo; Z Bian; L Yang; Y Chen; S Yan; X Xie; D Huang; J Chen; Z Chen; J Lv; L Li
Journal:  Osteoporos Int       Date:  2018-11-15       Impact factor: 4.507

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.